For instance, LNC942 (LINC00942) could enhance the mRNA stability and expression level of chemokine receptor 4 (CXCR4) and cytochrome P450 1B1 (CYP1B1) by cooperating with N6-methyladenine (m6A)-related protein methyltransferase-like 14 (METTL14), which could eventually inhibit apoptosis in breast cancer cells [47]. This evidence concerns the gene CYP1B1 and breast carcinoma.